Oncolytics Biotech Inc. Share Price Nasdaq
Equities
ONCY
CA6823108759
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | -0.93% | -1.83% | -20.74% |
Sales 2024 * | 10L 7L 6.12Cr | Sales 2025 * | 81.24L 59.57L 50Cr | Capitalization | 11Cr 8.12Cr 677.78Cr |
---|---|---|---|---|---|
Net income 2024 * | -3.4Cr -2.49Cr -208.09Cr | Net income 2025 * | -3.9Cr -2.86Cr -238.69Cr | EV / Sales 2024 * | 111 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 13.6 x |
P/E ratio 2024 * |
-3.67
x | P/E ratio 2025 * |
-3.97
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.1% |
Latest transcript on Oncolytics Biotech Inc.
1 day | -0.93% | ||
1 week | -1.83% | ||
1 month | -4.46% | ||
3 months | -4.46% | ||
6 months | -24.65% | ||
Current year | -20.74% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11/11/11 |
Kirk Look
DFI | Director of Finance/CFO | - | 01/03/01 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 07/22/07 |
Patricia Andrews
BRD | Director/Board Member | 66 | 09/01 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 08/15/08 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 1.07 | -0.93% | 94,788 |
30/24/30 | 1.08 | -0.92% | 82,055 |
29/24/29 | 1.09 | -0.91% | 175,038 |
28/24/28 | 1.1 | +0.92% | 184,281 |
24/24/24 | 1.09 | +2.83% | 250,852 |
Delayed Quote Nasdaq, May 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+37.52% | 3.88TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+25.12% | 1.22TCr | |
+0.04% | 1.22TCr | |
+26.04% | 1.19TCr |
- Stock Market
- Equities
- ONC Stock
- ONCY Stock